METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) TESTING SYSTEMS MARKET ANALYSIS

Regional Analysis

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global methicillin resistant staphylococcus aureus (MRSA) testing systems market over the forecast period. North America is estimated to hold 42.8% of the market share in 2023. North America methicillin resistant staphylococcus aureus (MRSA) testing systems market is expected to witness significant growth in the future, owing to expansion of product portfolio and launch of new products. For instance, in February 2021, Paratek Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company in the U.S., announced the expansion of the company’s commercial promotion of NUZYRA (omadacycline) is indicated for the treatment of adult patients with community-acquired bacterial pneumonia.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa